2006 related articles for article (PubMed ID: 9755229)
1. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
2. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Al Bokharhii J; Pappas C; Katsaraki A; Tsianos EV
Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036
[TBL] [Abstract][Full Text] [Related]
3. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.
Angeli P; Volpin R; Gerunda G; Craighero R; Roner P; Merenda R; Amodio P; Sticca A; Caregaro L; Maffei-Faccioli A; Gatta A
Hepatology; 1999 Jun; 29(6):1690-7. PubMed ID: 10347109
[TBL] [Abstract][Full Text] [Related]
4. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
Wong F; Pantea L; Sniderman K
Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
[TBL] [Abstract][Full Text] [Related]
5. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
[TBL] [Abstract][Full Text] [Related]
6. Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites.
Kalambokis G; Fotopoulos A; Economou M; Pappas K; Tsianos EV
J Hepatol; 2007 Feb; 46(2):213-21. PubMed ID: 17156883
[TBL] [Abstract][Full Text] [Related]
7. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
8. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration].
Ando M
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568
[TBL] [Abstract][Full Text] [Related]
9. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
11. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
Singh V; Dhungana SP; Singh B; Vijayverghia R; Nain CK; Sharma N; Bhalla A; Gupta PK
J Hepatol; 2012 Feb; 56(2):348-54. PubMed ID: 21749847
[TBL] [Abstract][Full Text] [Related]
12. Lack of renal effects of fish oil administration in patients with advanced cirrhosis and impaired glomerular filtration.
Badalamenti S; Salerno F; Salmeron JM; Lorenzano E; Rimola A; Ginés P; Jimenez W; Graziani G; Arroyo V; Rodes J; Ponticelli C
Hepatology; 1997 Feb; 25(2):313-6. PubMed ID: 9021940
[TBL] [Abstract][Full Text] [Related]
13. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
[TBL] [Abstract][Full Text] [Related]
14. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
Wong F; Raina N; Richardson R
Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
[TBL] [Abstract][Full Text] [Related]
15. Effect of dipyridamole on kidney function in cirrhosis.
Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
[TBL] [Abstract][Full Text] [Related]
16. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
17. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity.
Wong F; Logan A; Blendis L
Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419
[TBL] [Abstract][Full Text] [Related]
18. An effect of extrarenal beta adrenergic stimulation on the release of renin.
Reid IA; Schrier RW; Earley LE
J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
[TBL] [Abstract][Full Text] [Related]
19. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal.
Sansoè G; Silvano S; Mengozzi G; Smedile A; Todros L; Baronio M; Bonardi L; Rizzetto M
Am J Gastroenterol; 2002 Sep; 97(9):2383-90. PubMed ID: 12358261
[TBL] [Abstract][Full Text] [Related]
20. Midodrine and clonidine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
Singh V; Singh A; Singh B; Vijayvergiya R; Sharma N; Ghai A; Bhalla A
Am J Gastroenterol; 2013 Apr; 108(4):560-7. PubMed ID: 23419385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]